CD300e/LMIR6 Antibody (233810) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2705P
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Western Blot
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Recombinant Monoclonal Rat IgG2A Clone # 233810
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Y3 rat myeloid cell line transfected with human CD300e/LMIR6
Specificity
Detects human CD300e/LMIR6 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human LMIR1, 2, 3, 4, or 5 is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for CD300e/LMIR6 Antibody (233810) [PE]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD300e/LMIR6
Alternate Names
CD300e, CD300LE, CLM2, IREM-2, LMIR6
Gene Symbol
CD300E
Additional CD300e/LMIR6 Products
Product Documents for CD300e/LMIR6 Antibody (233810) [PE]
Product Specific Notices for CD300e/LMIR6 Antibody (233810) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...